Cystic fibrosis [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Oct 21, 2018

---

• Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis.
  Smith Daniel J et al. Gene 2018 Oct 12-17
• New therapies pack a triple-drug punch to treat cystic fibrosis
  A Cunningham, Science News, October 19, 2018
• Triple CFTR Modulator Therapy for Cystic Fibrosis
  F Holguin, NEJM, October 18, 2018
• VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
  D Keating et al, NEJM, October 18, 2018
• Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
  Grosse Scott D et al. Healthcare (Basel, Switzerland) 2015 3(4) 1133-57
• The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
  Grosse Scott D et al. The Milbank quarterly 2016 94(2) 366-91
• Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
  Korzeniewski Steven J et al. Pediatric pulmonology 2011 Feb 46(2) 125-30
• Cystic fibrosis survival: the changing epidemiology.
  Corriveau Sophie et al. Current opinion in pulmonary medicine 2018 Nov 24(6) 574-578
• Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His.
  Keenan Katherine et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2018 Sep
• Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles
  Shaw LP, et al. bioRxiv, Oct 5, 2018.

more